AntiCoagAF Downloads & RevenueAntiCoagAF · App Store
Not in any tracked top chart right now.
Updated 7 Nov 2026 · rankings refresh through the day
DeveloperCereScape Pty Ltd
CategoryMedical
Price1.99 EUR
Released
Rating★ 0.0 (0)
Version1.3.2
Age rating17+
First seen by us
16 Oct 2026
16 Oct 2026Full timeline · 3 events in the last 12 months
- 📈AntiCoagAF dropped out of every chart we trackLast seen 15 Oct
- 🆕AntiCoagAF first spotted by AppInsider#100 in Top Paid · All Apps · Netherlands
- 🆕AntiCoagAF released on the App Store
Collected from the stores by AppInsider since we first spotted the app. Dates are when we saw each change.
Rating
0.0 ★
0 ratings
Measured
AntiCoagAF on the App Store
App details
App ID
734858063
Publisher
CereScape Pty Ltd
On the store since
Nov 2013
12 years on the store
Minimum OS
iOS 16.6+
iPhone 8 and later
Devices
iPhone · iPad
Universal purchase
Content rating
17+
1 content note below
Languages
1
EN
Size
5 MB
Also listed in
Education
Content notesFrequent/Intense Medical/Treatment Information
Where it ranks now
Every top chart it appears in across 30 countries.
| Country | Charts | Rank |
|---|---|---|
| Not charting right now. | ||
Ratings
App Store, worldwide.
Rating
0.0 ★
0 ratings
Measured
Ratings
0
Measured
About AntiCoagAF
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Latest updates
1.3.2
Miscellaneous bug fixes and updated for iOS 16+.
